CSIMarket
 
Artemis Therapeutics Inc   (INKS)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 5
 Employees 1
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 0
 Cash Flow (TTM) (Millions $) -0
 Capital Exp. (TTM) (Millions $) 0

Artemis Therapeutics Inc
We are a biopharmaceutical company dedicated to the development of novel, safe, and effective agents for the prevention and treatment of severe and potentially life-threatening infectious diseases. Our lead product candidate, artemisone, is a clinical-stage synthetic artemisinin derivative with antiviral and antiparasitic properties. While artemisone is a clinical stage compound, as a result of prior development by third-parties, the Company’s development of artemisone for its proposed indications is in the pre-clinical phase. We expect to advance artemisone initially as an antiviral agent to address unmet clinical needs in the growing population of immunocompromised patients infected with human cytomegalovirus (HCMV), and other related clinical indications. While artemisone is a known chemical compound, that certain license agreement (the “License Agreement”) by and among the Company, Hadasit Medical Research Services and Development Ltd. (“Hadasit”) and Hong Kong University of Science and Technology R and D Corporation Limited (“RDC”) provides us with the exclusive right to further develop it.


   INKS is expected to report next financial results on August 14, 2020.
 

Umatrin Holding Ltd

Umatrin Holding Ltd announced fourth quarter operating deficit of $-0.016425 millions

Umatrin Holding Ltd announced earnings per share of $-0.00 and Sales of $0.31 millions in the fourth quarter, Company's reached break-even per share, versus $-0.00 eps, earned in the same quarter a year ago, although Umatrin Holding Ltd saw it's Sales rise by 128.76% in the same period.

Global Tech Industries Group Inc

Global Tech Industries Group Inc announced fourth quarter operating deficit of $-0.846682 millions

In the fourth quarter Global Tech Industries Group Inc reached break-even of $-0.00 per share compared to $-0.01 a year ago and from $0.00 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Notox Technologies Corp

Logged a Loss but Revenues Unchanged

In the second quarter Notox Technologies Corp lost money of $-0.01 per share compared to $-0.01 a year ago and from $0.00 per share from the previous quarter.

Sales remained unchanged to $0.77 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Grey Cloak Tech Inc

Company Fail to Break-even Despite Surge in Sales

Grey Cloak Tech Inc announced very strong Sales growth of 1697.68% year on year to $0.27 millions in the third quarter, but lost money at $-0.01.

International Stem Cell Corp

International Stem Cell Corp announced fourth quarter operating loss of $-2.485 millions

International Stem Cell Corp announced in the fourth quarter surge in Sales by 27.62% to $2.84 millions from the same quarter a year ago, but it has increased losses at $-0.36 per share.






   
Major Competitors Stock performance

5 Days Decrease / Increase
     
• View Complete Report
   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

AGMH's Profile

Stock Price

AGMH's Financials

Business Description

Fundamentals

Charts & Quotes

AGMH's News

Suppliers

AGMH's Competitors

Customers & Markets

Economic Indicators

AGMH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071